102 related articles for article (PubMed ID: 26662039)
21. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
22. Disparities in treatment and survival in early-stage hepatocellular carcinoma in California.
Gholami S; Kleber KT; Perry LM; Abidalhassan M; McFadden NR; Bateni SB; Maguire FB; Stewart SL; Morris C; Chen M; Gaskill CE; Merkow RP; Keegan TH
J Surg Oncol; 2023 Dec; 128(8):1302-1311. PubMed ID: 37610042
[TBL] [Abstract][Full Text] [Related]
23. Clinical features in hepatocellular carcinoma and the impact of autopsy on diagnosis. A study of 530 cases from a low-endemicity area.
Kaczynski J; Hansson G; Wallerstedt S
Hepatogastroenterology; 2005; 52(66):1798-802. PubMed ID: 16334780
[TBL] [Abstract][Full Text] [Related]
24. Survival of hepatocellular carcinoma patients is significantly improving: a population-based study from southern Switzerland.
Bordoni A; Cerny A; Bihl F; Alerci M; Mazzola P; Peverelli S; Marini G; Majno P; Mazzucchelli L; Spitale A
Cancer Epidemiol; 2014 Dec; 38(6):679-85. PubMed ID: 25454980
[TBL] [Abstract][Full Text] [Related]
25. Improving prognosis for patients with hepatocellular carcinoma in Ireland 1994-2008.
Gaynor C; Iqbal M; Comber H; Deady S; McCormick PA
Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):221-224. PubMed ID: 27832038
[TBL] [Abstract][Full Text] [Related]
26. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological and Clinical Patterns of Newly Diagnosed Hepatocellular Carcinoma in Brazil: the Need for Liver Disease Screening Programs Based on Real-World Data.
Fernandes GDS; Campos D; Ballalai A; Palhares R; da Silva MRA; Palhares DMF; Neto BF; Barros FMDR; Gil RA; Chagas A; Carrilho FJ
J Gastrointest Cancer; 2021 Sep; 52(3):952-958. PubMed ID: 32918274
[TBL] [Abstract][Full Text] [Related]
28. Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis.
Silveira MG; Suzuki A; Lindor KD
Hepatology; 2008 Oct; 48(4):1149-56. PubMed ID: 18785621
[TBL] [Abstract][Full Text] [Related]
29. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma over three decades in Victoria, Australia: epidemiology, diagnosis and trends, 1984-2013.
Carville KS; MacLachlan JH; Thursfield V; Cowie BC
Intern Med J; 2018 Jul; 48(7):835-844. PubMed ID: 29604152
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular carcinoma in Jos, Nigeria.
Echejoh GO; Tanko MN; Manasseh AN; Ogala-Echejoh S; Ugoya SO; Mandong BM
Niger J Med; 2008; 17(2):210-3. PubMed ID: 18686842
[TBL] [Abstract][Full Text] [Related]
32. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
Trevisani F; Santi V; Gramenzi A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
Am J Gastroenterol; 2007 Nov; 102(11):2448-57; quiz 2458. PubMed ID: 17617210
[TBL] [Abstract][Full Text] [Related]
33. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound surveillance for hepatocellular carcinoma of at-risk patients in Ramathibodi Hospital.
Prapruttam D; Suksai J; Kitiyakara T; Phongkitkarun S
J Med Assoc Thai; 2014 Nov; 97(11):1199-208. PubMed ID: 25675686
[TBL] [Abstract][Full Text] [Related]
35. [Hepatocellular carcinoma in Korea: introduction and overview].
Park JW
Korean J Gastroenterol; 2005 Apr; 45(4):217-26. PubMed ID: 15843747
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma incidence in Florida. Ethnic and racial distribution.
Shea KA; Fleming LE; Wilkinson JD; Wohler-Torres B; McKinnon JA
Cancer; 2001 Mar; 91(5):1046-51. PubMed ID: 11251958
[TBL] [Abstract][Full Text] [Related]
37. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres.
Cazzagon N; Trevisani F; Maddalo G; Giacomin A; Vanin V; Pozzan C; Poggio PD; Rapaccini G; Nolfo AM; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Foschi FG; Cabibbo G; Felder M; Ciccarese F; Missale G; Baroni GS; Morisco F; Pecorelli A; Farinati F;
Liver Int; 2013 Oct; 33(9):1420-7. PubMed ID: 23758775
[TBL] [Abstract][Full Text] [Related]
38. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry.
Wong RJ; Devaki P; Nguyen L; Cheung R; Nguyen MH
Liver Transpl; 2014 May; 20(5):528-35. PubMed ID: 24415542
[TBL] [Abstract][Full Text] [Related]
39. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Nguyen VT; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
[TBL] [Abstract][Full Text] [Related]
40. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).
Vinayak R; Cruz RJ; Ranganathan S; Mohanka R; Mazariegos G; Soltys K; Bond G; Tadros S; Humar A; Marsh JW; Selby RR; Reyes J; Sun Q; Haberman K; Sindhi R
Liver Transpl; 2017 Dec; 23(12):1577-1588. PubMed ID: 28834194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
